Search

Your search keyword '"Warlam-Rodenhuis, C.C."' showing total 16 results
Start Over Author "Warlam-Rodenhuis, C.C."
16 results on '"Warlam-Rodenhuis, C.C."'

1. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial

Author

Poortmans, P.M., Collette, L., Bartelink, H., Struikmans, H., Van den Bogaert, W.F., Fourquet, A., Jager, J.J., Hoogenraad, W., Müller, R.-P., Dubois, J.-B., Bolla, M., Van Der Hulst, M., Wárlám-Rodenhuis, C.C., Pierart, M., and Horiot, J.-C.

Published
2008
Full Text
View/download PDF

2. FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA

Author

Creutzberg, C.L., Nout, R.A., Lybeert, M.L.M., Warlam-Rodenhuis, C.C., Jobsen, J.J., Mens, J.W.M., Lutgens, L.C.H.W., Pras, E., Poll-Franse, L.V. van de, Putten, W.L.J. van, PORTEC Study Grp, Medical and Clinical Psychology, Radiotherapie, and RS: GROW - School for Oncology and Reproduction

Subjects
Oncology, Cancer Research, INTERMEDIATE-RISK, medicine.medical_treatment, ComputingMilieux_LEGALASPECTSOFCOMPUTING, GYNECOLOGIC-ONCOLOGY-GROUP, law.invention, ADJUVANT CHEMOTHERAPY, POSTOPERATIVE RADIOTHERAPY, Quality of life, Randomized controlled trial, QUALITY-OF-LIFE, law, Stage (cooking), Aged, 80 and over, Radiation, Neoplasms, Second Primary, PHASE-III TRIAL, Middle Aged, Prognosis, LYMPHVASCULAR SPACE INVOLVEMENT, Radiation therapy, Treatment Outcome, Radiology Nuclear Medicine and imaging, Female, Randomized trial, PELVIC RADIATION-THERAPY, Adult, Risk, medicine.medical_specialty, Vaginal Neoplasms, Breast Neoplasms, Endometrial carcinoma, Prognostic factors, Disease-Free Survival, Stage ib, Internal medicine, Carcinoma, medicine, Humans, Radiology, Nuclear Medicine and imaging, External beam radiotherapy, Aged, Analysis of Variance, Intention-to-treat analysis, business.industry, medicine.disease, Long-term outcome, Endometrial Neoplasms, Surgery, CANCER MRC ASTEC, EXTERNAL-BEAM RADIOTHERAPY, Neoplasm Grading, Neoplasm Recurrence, Local, business
Abstract

Purpose: To evaluate the very long-term results of the randomized Post Operative Radiation Therapy in Endometrial Carcinoma (PORTEC)-1 trial for patients with Stage I endometrial carcinoma (EC), focusing on the role of prognostic factors for treatment selection and the long-term risk of second cancers.Patients and Methods: The PORTEC trial (1990-1997) included 714 patients with Stage IC Grade 1-2 or Stage IB Grade 2-3 EC. After surgery, patients were randomly allocated to external-beam pelvic radiotherapy (EBRT) or no additional treatment (NAT). Analysis was by intention to treat.Results: 426 patients were alive at the date of analysis. The median follow-up time was 13.3 years. The 15-year actuarial locoregional recurrence (LRR) rates were 6% for EBRT vs. 15.5% for NAT (p 60 (HR 3.9, p = 0.002 for LRR and 2.7, p = 0.01 for EC death) and myometrial invasion > 50% (HR 1.9, p = 0.03 and HR 1.9, p = 0.02).Conclusions: The 15-year outcomes of PORTEC-1 confirm the relevance of HIR criteria for treatment selection, and a trend for long-term risk of second cancers. EBRT should be avoided in patients with low-and intermediate-risk EC. (C) 2011 Elsevier Inc.

Published
2011

4. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The postoperative radiation therapy in endometrial carcinoma trial: The postoperative radiation therapy in endometrial carcinoma trial

Author

Creutzberg, C.L., van Putten, W.L.J., Warlam-Rodenhuis, C.C., Van den Bergh, A.C.M., De Winter, K.A.J., Koper, P.C.M., Lybeert, M.L.M., Slot, A., Lutgens, L.C.H.W., Kroese, M.C.S., Beerman, H., van Lent, M., and Guided Treatment in Optimal Selected Cancer Patients

Subjects
SURVIVAL COMPARISONS, BRACHYTHERAPY, PROGNOSTIC FACTORS, EXTERNAL IRRADIATION, PATTERNS, FAILURE, ADENOCARCINOMA, ADJUVANT RADIATION, CANCER, RADIOTHERAPY
Published
2004

5. Surgery and postoperative radiotherapy vs. surgery alone for patients with endometrial cancer: multicenter randomized trial Portec Study Group

Author

Creutzberg, C.L., Putten, W.L.J. van, Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., Winter, K.A. de, Lutgens, L.C., Bergh, M.F.Q. van den, Steen-Banasik, E.M. van der, Beerman, H., and Lent, M. van

Subjects
Experimentele radiotherapie en neuro-oncologie, Experimental radiotherapy and neuro-oncology
Abstract

Contains fulltext : 184645.pdf (Publisher’s version ) (Closed access)

Published
2000

10. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial

Author

Creutzberg, C.L, primary, Van Putten, W.L, additional, Koper, P.C, additional, Lybeert, M.L, additional, Jobsen, J.J, additional, Warlam-Rodenhuis, C.C, additional, De Winter, K.A, additional, Lutgens, L.C, additional, Van den Bergh, A.C, additional, Van der Steen-Banasik, E, additional, Beerman, H, additional, and van Lent, M, additional

Published
2002
Full Text
View/download PDF

12. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

Author

Creutzberg, C.L, primary, Van Putten, W.L.J, additional, Koper, P.C.M, additional, Lybeert, M.L.M, additional, Jobsen, J.J, additional, Warlam-Rodenhuis, C.C, additional, De Winter, K.A.J, additional, Lutgens, L.C.H.W, additional, Van den Bergh, A.C.M, additional, de Steen-Banasik, E, additional, and Beerman, H, additional

Published
2001
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results